Top 10 Companies in the (S)-2-Heptylamine (CAS 44745-29-1) Market (2026): Market Leaders Powering Global Demand

MARKET INSIGHTS

Global (S)-2-Heptylamine (CAS 44745-29-1) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 7.2% during the forecast period.

(S)-2-Heptylamine (CAS 44745-29-1) is a chiral primary amine compound with the molecular formula C₇H₁₇N, recognized for its enantiopure (S)-configuration. It serves as a critical building block and chiral auxiliary in asymmetric synthesis, pharmaceutical intermediate development, and agrochemical manufacturing. The compound finds application across fine chemical synthesis, resolving agents, and the production of optically active substances where stereochemical precision is essential.

The market is witnessing steady growth driven by the expanding demand for chiral intermediates in pharmaceutical development, particularly as drug manufacturers increasingly prioritize single-enantiomer compounds for improved therapeutic efficacy and reduced side effects. Furthermore, the rising investment in asymmetric catalysis research and the broader growth of the specialty chemicals sector are reinforcing market expansion. Key producers and fine chemical suppliers operating globally continue to strengthen their chiral amine portfolios to meet evolving industry requirements.

(S)-2-Heptylamine (CAS 44745-29-1) Market – View in Detailed Research Report

MARKET DRIVERS

Rising demand in pharmaceutical synthesis and expansion in agrochemical applications are the primary drivers of the (S)-2-Heptylamine market. The compound’s role as a chiral building block in drug development and its use in enantioselective pesticides and herbicides have spurred volume growth. The market is projected to grow at a 6.2% CAGR through 2030, fueled by over 15% annual increase in chiral amine usage in fine chemicals.

MARKET CHALLENGES

Supply chain vulnerabilities and high production costs are significant challenges. Complex chiral resolution processes make the supply chain susceptible to disruptions from raw material shortages and specialized equipment needs. High purity requirements amplify costs, challenging smaller manufacturers to compete effectively. Regulatory compliance hurdles, including stringent REACH and EPA guidelines, further delay market entry and increase R&D expenditures.

TOP 10 COMPANIES IN THE (S)-2-Heptylamine MARKET

1. BASF SE
   Headquarters: Ludwigshafen, Germany
   Key Offering: Pharmaceutical grade (S)-2-Heptylamine for API synthesis, agrochemical intermediates, and specialty fine chemicals.

   BASF’s robust production capabilities and extensive R&D investments enable it to supply high-purity (S)-2-Heptylamine at scale. The company’s focus on green chemistry and process optimization aligns with global sustainability goals.

   • Advanced asymmetric synthesis processes
   • Strong global supply chain with long-term contracts
   • Continuous investment in chiral technology and automation

2. Evonik Industries AG
   Headquarters: Essen, Germany
   Key Offering: Specialty chiral amines for pharmaceutical intermediates, agrochemicals, and fine chemical applications.

   Evonik’s high-purity manufacturing processes and compliance with stringent regulatory standards make it a preferred supplier for pharma and agrochemical sectors.

   • Proprietary biocatalytic platforms
   • Integrated R&D and production facilities
   • Commitment to reducing environmental footprint through energy-efficient processes

3. Lonza Group Ltd.
   Headquarters: Basel, Switzerland
   Key Offering: Custom synthesis of chiral intermediates, including (S)-2-Heptylamine, for pharma and biotech companies.

   Lonza’s flexible manufacturing and rapid lead times support the fast-paced pharmaceutical R&D cycle.

   • Dedicated contract manufacturing services
   • Advanced analytical capabilities for purity verification
   • Strong focus on customer collaboration and innovation

4. Biosynth AG
   Headquarters: Basel, Switzerland
   Key Offering: High-value custom synthesis of chiral amines, including (S)-2-Heptylamine, for specialty chemical and pharmaceutical clients.

   Biosynth’s acquisition of Carbosynth has expanded its portfolio and capacity for bespoke chiral synthesis.

   • State-of-the-art biocatalysis facilities
   • Strong global distribution network
   • Emphasis on quality and regulatory compliance

5. Capot Chemical Co., Ltd.
   Headquarters: Shanghai, China
   Key Offering: Cost-competitive production of pharmaceutical and agrochemical intermediates, including (S)-2-Heptylamine.

   Capot’s rapid scaling and agile production model enable it to meet rising demand in the Asia-Pacific region.

   • Advanced enzymatic resolution techniques
   • Integrated quality management system
   • Focus on process efficiency and cost reduction

6. Tokyo Chemical Industry Co., Ltd. (TCI)
   Headquarters: Tokyo, Japan
   Key Offering: Precision chemicals for research and development, including high-purity (S)-2-Heptylamine.

   TCI’s expertise in fine chemicals and research applications positions it as a leader in the niche chiral market.

   • Strong research & development pipeline
   • High standards for purity and enantiomeric excess
   • Collaboration with academic and industrial partners

7. PharmaBlock Sciences Co., Ltd.
   Headquarters: Beijing, China
   Key Offering: Custom synthesis of chiral intermediates for pharmaceutical and biotech companies.

   PharmaBlock’s rapid lead times and flexible manufacturing make it a preferred partner for emerging pharma players.

   • Modular production facilities
   • Advanced process control systems
   • Commitment to regulatory compliance and quality

8. Hairui Fine Chemical Co., Ltd.
   Headquarters: Shanghai, China
   Key Offering: Fine chemical intermediates, including (S)-2-Heptylamine, for agrochemical and pharmaceutical markets.

   Hairui’s focus on high-purity grades and efficient production supports its growing customer base.

   • Integrated synthesis and purification processes
   • Strong supply chain management
   • Investment in green chemistry initiatives

9. Finetech Industry Limited
   Headquarters: Shenzhen, China
   Key Offering: Specialty chiral amines for fine chemical and agrochemical applications.

   Finetech’s rapid scaling and cost-effective production methods cater to the Asia-Pacific market.

   • High-throughput synthesis platforms
   • Focus on cost optimization
   • Strong compliance with international quality standards

10. Siegfried Holding AG
    Headquarters: Basel, Switzerland
    Key Offering: High-purity chiral amines for pharmaceutical and fine chemical applications.

    Siegfried’s long-standing expertise in chiral chemistry and quality control makes it a trusted supplier.

    • Advanced resolution technologies
    • Robust quality assurance programs
    • Commitment to sustainable manufacturing

Download FREE Sample Report: Download FREE Sample Report

Get Full Report: Get Full Report

OUTLOOK

The (S)-2-Heptylamine market is poised for robust growth, driven by increasing demand for enantiopure intermediates in pharmaceutical and agrochemical sectors. The expanding focus on single-enantiomer drugs, coupled with advancements in asymmetric catalysis and biocatalytic processes, is expected to reduce production costs and enhance supply chain resilience. Global supply chains are becoming more integrated, with key players investing in capacity expansions and green chemistry initiatives to meet regulatory and environmental standards.

FUTURE TRENDS

Emerging trends include the rapid adoption of biocatalytic and enzymatic resolution methods, which offer lower energy consumption and higher selectivity. The push toward green chemistry is leading to the development of sustainable processes that reduce waste and improve safety. Digitalization and AI-driven demand forecasting are improving supply chain efficiency, while strategic partnerships between chemical manufacturers and pharmaceutical companies are accelerating the development of custom chiral intermediates. These trends are expected to drive double-digit growth in high-value segments and expand the application portfolio of (S)-2-Heptylamine into new markets such as specialty surfactants for cosmetics and personal care products.